Franklin FTSE South Korea ETF vs Tilray Brands Inc — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.88B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: Franklin FTSE South Korea ETF is far larger — about 3.4× Tilray Brands Inc's market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Tilray Brands Inc for 31 Days on average.
| FLKR | TLRY | |
|---|---|---|
Market Cap | $1.88B | $549.01M |
Volume | 709,775 | 3,292,073 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $21.00 |
52-Week Low | $27.09 | $3.57 |
Typical Hold Time | 15 Days | 31 Days |
Enterprise Value | — | $716.15M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →